Segeberg registry for mitral clip (M-TEER) in severe mitral regurgitation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center registry enrolling all patients treated with transcatheter edge-to-edge mitral repair (M-TEER) at the Heart Center, Bad Segeberg. Patients undergo a routine clinical follow-up schedule that includes clinical visits and imaging over the long term. Procedural details, in-hospital outcomes, and subsequent clinical events are recorded in a database. The registry aims to capture real-world safety, durability of repair, and patient-centered outcomes after M-TEER.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with severe MR undergoing M-TEER

Exclusion Criteria:

* None

Where it's running

• Herzzentrum Segeberger Kliniken GmbH
  Bad Segeberg, Schleswig-Holstein, Germany Recruiting

Study contacts

• Study coordinator: Arief Kurniadi, MD
• Email: arief.kurniadi@segebergerkliniken.de
• Phone: +4945512802

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Capstan TMVR Feasibility for Mitral Regurgitation

  This early feasibility study tests the Capstan Compass Robotic System to replace the mitral valve in adults with symptomatic, moderate-to-severe or severe mitral regurgitation who aren’t candidates for surgical repair or standard edge-to-edge repair.

  Recruiting Capstan Medical · San Francisco, California and 2 other locations · NCT07917208

• Transcatheter repair for atrial functional mitral regurgitation in high-risk patients

  This trial tests whether adding a catheter-based mitral valve repair (TEER) to optimized medical therapy helps adults with atrial functional MR who are at high surgical risk.

  Recruiting China National Center for Cardiovascular Diseases · Beijing · NCT07741253

• MitraFix transcatheter mitral valve system for high-risk severe mitral regurgitation

  This trial will test the MitraFix transcatheter mitral valve system to see if it can be safely implanted and reduce severe leaky mitral valves in adults at high risk for open-heart surgery.

  Recruiting Mitrassist Lifesciences Limited Co., Ltd. · Beijing, Beijing Municipality · NCT07501234

• DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease

  This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.

  Recruiting Columbia University · New York, New York · NCT07197736

• Assessing risks and outcomes in patients with mitral regurgitation

  This study looks at patients with moderate to severe mitral regurgitation to see what factors might affect their health outcomes and help doctors make better treatment decisions.

  Recruiting Sun Yat-sen University · Guangzhou, Guangdong · NCT06876883

• Comparing early mitral valve repair to watchful waiting for asymptomatic severe mitral regurgitation

  This study is testing if early surgery for the mitral valve can help people with severe mitral regurgitation live longer and healthier compared to just keeping an eye on their condition.

  Recruiting at 2 sites Centre Hospitalier Universitaire, Amiens · Amiens and 1 other locations · NCT03389542

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.